Prenatal Lead (Pb) Exposure and Peripheral Blood DNA Methylation (5mC) and Hydroxymethylation (5hmC) in Mexican Adolescents from the ELEMENT Birth Cohort
Abstract:Background:
Gestational lead (Pb) exposure can adversely affect offspring health through multiple mechanisms, including epigenomic alterations via DNA methylation (5mC) and hydroxymethylation (5hmC), an intermediate in oxidative demethylation. Most current methods do not distinguish between 5mC and 5hmC, limiting insights into their individual roles.
Objective:
Our study sought to identify the association of trimester-specific (T1, T2, T3) prenatal Pb exposure with 5mC … Show more
“…For example, DNA methylation at promoters is generally associated with repression of genes, while intragenic DNA methylation is associated with gene activation [ 53 , 54 ]. The 5-hydroxymethylcytosine (5hmC) modification plays a critical role post-fertilization and in primordial germ cells (PGCs) during the dynamic reprogramming of DNA methylation [ 55 - 57 ] but has also been shown to be a stable epigenetic mark present in a variety of mammalian tissues [ 58 - 60 ], and we have shown that it is stably reprogrammed by perinatal exposures in mice and humans [ 61 , 62 ].…”
Section: Introductionmentioning
confidence: 99%
“…Human studies investigating the effects of developmental Pb exposure on the epigenome have focused primarily on the measurement of Pb in maternal blood, maternal tibia or patella, cord blood, or neonatal blood spots as proxies for Pb exposure during pregnancy. These studies have repeatedly demonstrated that Pb exposure is associated with changes in DNA methylation and hydroxymethylation in offspring blood [ 62 , 124 - 126 ], and sex differences have been reported [ 125 - 127 ]. Moreover, recent work suggests that maternal Pb-induced changes in DNA methylation may be transmitted to grandchildren [ 128 ].…”
Despite substantial strides in diagnosis and treatment, cardiovascular diseases (CVDs) continue to represent the leading cause of death in the US and around the world, resulting in significant morbidity and loss of productive years of life. It is increasingly evident that environmental exposures during early development can influence CVD risk across the life course. CVDs exhibit marked sexual dimorphism, but how sex interacts with environmental exposures to affect cardiovascular health is a critical and understudied area of environmental health. Emerging evidence suggests that developmental exposures may have multi- and transgenerational effects on cardiovascular health, with potential sex differences; however, further research in this important area is urgently needed. Lead (Pb), phthalate plasticizers, and perfluoroalkyl substances (PFAS) are ubiquitous environmental contaminants with numerous adverse human health effects. Notably, recent evidence suggests that developmental exposure to each of these toxicants has sex-specific effects on cardiovascular outcomes, but the underlying mechanisms, and their effects on future generations, require further investigation. This Review Article will highlight the role for the developmental environment in influencing cardiovascular health across generations, with a particular emphasis on sex differences and epigenetic mechanisms In particular, we will focus on the current evidence for adverse multi and transgenerational effects of developmental exposures to Pb, phthalates, and PFAS, and highlight areas where further research is needed.
“…For example, DNA methylation at promoters is generally associated with repression of genes, while intragenic DNA methylation is associated with gene activation [ 53 , 54 ]. The 5-hydroxymethylcytosine (5hmC) modification plays a critical role post-fertilization and in primordial germ cells (PGCs) during the dynamic reprogramming of DNA methylation [ 55 - 57 ] but has also been shown to be a stable epigenetic mark present in a variety of mammalian tissues [ 58 - 60 ], and we have shown that it is stably reprogrammed by perinatal exposures in mice and humans [ 61 , 62 ].…”
Section: Introductionmentioning
confidence: 99%
“…Human studies investigating the effects of developmental Pb exposure on the epigenome have focused primarily on the measurement of Pb in maternal blood, maternal tibia or patella, cord blood, or neonatal blood spots as proxies for Pb exposure during pregnancy. These studies have repeatedly demonstrated that Pb exposure is associated with changes in DNA methylation and hydroxymethylation in offspring blood [ 62 , 124 - 126 ], and sex differences have been reported [ 125 - 127 ]. Moreover, recent work suggests that maternal Pb-induced changes in DNA methylation may be transmitted to grandchildren [ 128 ].…”
Despite substantial strides in diagnosis and treatment, cardiovascular diseases (CVDs) continue to represent the leading cause of death in the US and around the world, resulting in significant morbidity and loss of productive years of life. It is increasingly evident that environmental exposures during early development can influence CVD risk across the life course. CVDs exhibit marked sexual dimorphism, but how sex interacts with environmental exposures to affect cardiovascular health is a critical and understudied area of environmental health. Emerging evidence suggests that developmental exposures may have multi- and transgenerational effects on cardiovascular health, with potential sex differences; however, further research in this important area is urgently needed. Lead (Pb), phthalate plasticizers, and perfluoroalkyl substances (PFAS) are ubiquitous environmental contaminants with numerous adverse human health effects. Notably, recent evidence suggests that developmental exposure to each of these toxicants has sex-specific effects on cardiovascular outcomes, but the underlying mechanisms, and their effects on future generations, require further investigation. This Review Article will highlight the role for the developmental environment in influencing cardiovascular health across generations, with a particular emphasis on sex differences and epigenetic mechanisms In particular, we will focus on the current evidence for adverse multi and transgenerational effects of developmental exposures to Pb, phthalates, and PFAS, and highlight areas where further research is needed.
“…Numerous recent studies have highlighted the critical role for DNA hydroxymethylation in the context of environmental exposures and disease. − DNA hydroxymethylation entails the oxidative conversion of 5-methylcytosine to 5-hydroxymethylcytosine by TET dioxygenases. , While 5-hydroxymethylcytosine is an intermediate in the process of active DNA demethylation, it is also now considered to be a stable epigenetic modification and is associated with regulation of gene expression and alternative splicing. − TET dioxygenases convert 5-methylcytosine to 5-hydroxymethylcytosine using iron (Fe II), α-ketoglutarate, and vitamin C as cofactors, and can also catalyze the further oxidation of 5-hydroxymethylcytosine to 5-formylcytosine and 5-carboxylcytosine. , Like 5-hydroxymethylcytosine, 5-formylcytosine and 5-carboxylcytosine are intermediates in the process of demethylation of DNA through both replication-dependent dilution as well as pathways involving DNA repair enzymes such as thymine DNA glycosylase. , Three TET dioxygenases, TET1, TET2, and TET3 have been identified and each show distinct expression patterns during normal development and in differentiated tissues. , TETs are most highly expressed in embryonic stem cells and during early development, where they function in active DNA demethylation during both waves of reprogramming. 5-Hydroxymethylcytosine is present to a notable degree in embryonic stem cells and the brain. − The specific role of 5-hydroxymethylcytosine in the brain is only beginning to be characterized, but there is evidence to suggest it plays a role in neurodevelopment and aging, and its aberrant expression is implicated in several neurological disorders. , Furthermore, 5-hydroxymethylcytosine is influenced by the environment, with exposures such as arsenic, lead, and pesticides associated with alterations in 5-hydroxymethylcytosine in the brain and blood. ,, Future studies will undoubtedly continue to clarify the role for 5-hydroxymethylcytosine in normal neurodevelopment, environmental health, and disease.…”
Section: Background: Types Of Epigenetic Informationmentioning
confidence: 99%
“…48,49 Furthermore, 5-hydroxymethylcytosine is influenced by the environment, with exposures such as arsenic, lead, and pesticides associated with alterations in 5-hydroxymethylcytosine in the brain and blood. 8,34,50 Future studies will undoubtedly continue to clarify the role for 5-hydroxymethylcytosine in normal neurodevelopment, environmental health, and disease. Programming of DNA Methylation and Hydroxymethylation During Development.…”
The rapidly growing field of toxicoepigenetics seeks
to understand
how toxicant exposures interact with the epigenome to influence disease
risk. Toxicoepigenetics is a promising field of environmental health
research, as integrating epigenetics into the field of toxicology
will enable a more thorough evaluation of toxicant-induced disease
mechanisms as well as the elucidation of the role of the epigenome
as a biomarker of exposure and disease and possible mediator of exposure
effects. Likewise, toxicoepigenetics will enhance our knowledge of
how environmental exposures, lifestyle factors, and diet interact
to influence health. Ultimately, an understanding of how the environment
impacts the epigenome to cause disease may inform risk assessment,
permit noninvasive biomonitoring, and provide potential opportunities
for therapeutic intervention. However, the translation of research
from this exciting field into benefits for human and animal health
presents several challenges and opportunities. Here, we describe four
significant areas in which we see opportunity to transform the field
and improve human health by reducing the disease burden caused by
environmental exposures. These include (1) research into the mechanistic
role for epigenetic change in environment-induced disease, (2) understanding
key factors influencing vulnerability to the adverse effects of environmental
exposures, (3) identifying appropriate biomarkers of environmental
exposures and their associated diseases, and (4) determining whether
the adverse effects of environment on the epigenome and human health
are reversible through pharmacologic, dietary, or behavioral interventions.
We then highlight several initiatives currently underway to address
these challenges.
“…5'-Methylcytosine (5mC) is the main form of DNA methylation and one of the earliest and most thoroughly studied epigenetic regulatory mechanisms, playing an important role in cancer, gene expression, aging, atherosclerosis, Alzheimer's disease and other diseases [15][16][17]. Studies have shown that the increased expression of hTERT in colorectal cancer and gastric cancer was associated with the degree of hypermethylation of the hTERT gene, which seriously affected recurrence after treatment [18,19].…”
Avian leukosis virus subgroup J (ALV-J) can cause neoplastic diseases in poultry and is still widely prevalent in China. Chicken telomerase reverse transcriptase (chTERT) is the core component of telomerase, which is closely related to the occurrence and development of tumors. Our previous studies showed that chTERT is overexpressed in ALV-J tumors, but the mechanism is still not completely clear. Therefore, this study aims to analyze the possible molecular mechanism of chTERT overexpression in ALV-J tumors from the perspective of DNA methylation and promoter mutation. Methylation sequencing of the chTERT amplicon showed that ALV-J replication promoted the methylation level of the chTERT promoter. And the methylation level of the chTERT promoter in ALV-J tumors was significantly higher than that in tumor-adjacent and normal tissues. Compared with the tumor-adjacent and normal tissues, the chTERT promoter in each ALV-J tumors tested had a mutation of −183 bp C > T, and 36.0% (9/25) of the tumors also had mutations of −184 bp T > C, −73 bp::GGCCC and −56 bp A > T in the chTERT promoter, which formed the binding sites for the transcription factors NFAT5, TFAP2A and ZEB1, respectively. The results of RT–qPCR and Western blotting showed that the occurrence of these mutations significantly increased the expression level of chTERT. In conclusion, this study demonstrated that the high expression of chTERT in ALV-J tumors is positively correlated with the level of hypermethylation and mutation in its promoter, which provides a new perspective for further research on the molecular mechanism of chTERT in ALV-J tumorigenesis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.